Ayala Pharmaceuticals RPE
What is the RPE of Ayala Pharmaceuticals?
The RPE of Ayala Pharmaceuticals Inc. is $11.111k
What is the definition of RPE?
Revenue per employee (RPE) is revenue divided by the number of employees of an organization.
= net income / number of employees
RPE of companies in the Health Care sector on NASDAQ compared to Ayala Pharmaceuticals
What does Ayala Pharmaceuticals do?
advaxis (nasdaq: adxs) is a late -stage biotechnology company developing multiple cancer immunotherapies based on its proprietary platform that redirects the immune system to kill cancer. the advaxis technology, using bioengineered live attenuated bacteria, listeria monocytogenes (lm), actively suppresses key components in the tumor microenvironment that contribute to the tumors growth and protection from immunologic attack.
Companies with rpe similar to Ayala Pharmaceuticals
- International General Insurance Ltd has RPE of $10.651k
- Casino, Guichard-Perrachon SA has RPE of €10.771k
- RE/MAX Inc has RPE of $10.785k
- Oncocyte has RPE of $10.883k
- Watchstone Plc has RPE of £10.958k
- 4Dx has RPE of AUD$11.098k
- Ayala Pharmaceuticals has RPE of $11.111k
- ANGLE Plc has RPE of £11.137k
- DynaCERT has RPE of CAD$11.150k
- Aguia Resources has RPE of AUD$11.200k
- ASA International PLC has RPE of $11.320k
- Verona Pharma Plc has RPE of $11.450k
- GOME Retail has RPE of ¥11.455k